Krystal Biotech Inc (KRYS)

Deferred Revenue

$83.48M

Quarterly · Period ending: · USD

KRYS logo

KRYS Deferred Revenue

Latest reported$83.48M
KRYS Quarterly Deferred Revenue ($0.00 → $83.48M)
High-resolution chart · PNG

KRYS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
83,480,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961,000
2,202,000
1,470,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.